PDCD1 and neoplasm: Molecules like programmed cell death-1 (PD-1) ligands (PD-L1 and PD-L2) are upregulated on tumor cells, impeding the activation of PD-1+ effector cells upon ligand-receptor interaction (Sharma and Allison James, 2015).